arrow
E

Elena Cortés-Vicente

hospital de la santa creu i sant pau
H指数:23
被引数:1,702

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Variability and Genotype-Driven Outcomes in CHRND-Related Congenital Myasthenic Syndrome

CHRND相关先天性肌无力综合征的临床变异性和基因型驱动的结局

2026-09-040
OAAI
Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort

方法学见解与ALS及FTLD的临床结局:SPIN队列的经验

2026-08-280
OAAI
278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The Netherlands

第278届ENMC国际研讨会:重症肌无力登记系统的欧洲标准化与新兴数字解决方案。2024年9月20日至21日,荷兰霍夫多普。

2025-06-010
PRE
ADAPT NXT: Fixed Cycles or Every-Other-Week IV Efgartigimod in Generalized Myasthenia Gravis

适应NXT: 固定周期或每隔一周静脉注射Efgartigimod治疗全身性重症肌无力

2025-04-010
OAAI
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data
2025-03-110
OAAI
Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis

肌萎缩侧索硬化患者ARPP21致病突变的鉴定

2024-07-021
PRE
Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology
2024-05-013
OAAI
Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum

额颞叶变性-运动神经元疾病谱的临床病理相关性

BRAIN
IF11.7
2024-01-162
OAAI
Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis
2023-04-040
OAAI
Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
2022-07-0113
OAAI